Symbol="ALLR"
AssetType="Common Stock"
Name="Allarity Therapeutics Inc"
Description="Allarity Therapeutics A / S develops various therapeutic candidates for the treatment of cancer using complementary drug-specific diagnostics (cDx) generated by its drug response prediction technology. The company is headquartered in Horsholm, Denmark."
CIK="1860657"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="210 BROADWAY, SUITE 201, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2599600"
EBITDA="-16202000"
PERatio="None"
PEGRatio="None"
BookValue="-104.41"
DividendPerShare="0"
DividendYield="0"
EPS="-178.2"
RevenuePerShareTTM="-0.018"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.462"
ReturnOnEquityTTM="-1.975"
RevenueTTM="-7127000"
GrossProfitTTM="-36348000"
DilutedEPSTTM="-178.2"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="2.659"
EVToRevenue="-"
EVToEBITDA="-0.0989"
Beta="-0.0032"
num_52WeekHigh="2435.86"
num_52WeekLow="2.95"
num_50DayMovingAverage="9.69"
num_200DayMovingAverage="364.08"
SharesOutstanding="860790"
DividendDate="None"
ExDividendDate="None"
symbol="ALLR"
open="3.15"
high="3.26"
low="2.95"
price="3.02"
volume="386011.00"
latest_trading_day="2023-07-14"
previous_close="3.18"
change="-0.16"
change_percent="-5.0314%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="4135878"
Change_recent_avg="-0.01"
Delta_recent_avg="0.27"
Variance_recent_avg="0.14"
Change_ratio_recent_avg="-3.37"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1101"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0134.jpeg"
image_negative_thumbnail_id_2="507"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0098.jpeg"
image_neutral_thumbnail_id_1="541"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0058.jpeg"
image_neutral_thumbnail_id_2="566"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_positive_thumbnail_id_1="998"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0160.jpeg"
image_positive_thumbnail_id_2="996"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0158.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
